Order Article Reprints

Mortuza S, Chin-Yee B, James TE, Chin-Yee IH, Hedley BD, Ho JM, Saini L, Lazo-Langner A, Schenkel L, Bhai P, et al. Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or SF3B1 Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review. Current Oncology. 2024; 31(4):1762-1773. https://doi.org/10.3390/curroncol31040134

Mortuza, Shamim, Benjamin Chin-Yee, Tyler E. James, Ian H. Chin-Yee, Benjamin D. Hedley, Jenny M. Ho, Lalit Saini, Alejandro Lazo-Langner, Laila Schenkel, Pratibha Bhai, and et al. 2024. "Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or SF3B1 Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review" Current Oncology 31, no. 4: 1762-1773. https://doi.org/10.3390/curroncol31040134

Mortuza, S., Chin-Yee, B., James, T. E., Chin-Yee, I. H., Hedley, B. D., Ho, J. M., Saini, L., Lazo-Langner, A., Schenkel, L., Bhai, P., Sadikovic, B., Keow, J., Sangle, N., & Hsia, C. C. (2024). Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or SF3B1 Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review. Current Oncology, 31(4), 1762-1773. https://doi.org/10.3390/curroncol31040134